Skip to main content
    • Aa
    • Aa
  • Access
  • Cited by 63
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Ahl, D. Liu, H. Schreiber, O. Roos, S. Phillipson, M. and Holm, L. 2016. Lactobacillus reuteriincreases mucus thickness and ameliorates dextran sulphate sodium-induced colitis in mice. Acta Physiologica, Vol. 217, Issue. 4, p. 300.

    Thomas, Carissa M. Saulnier, Delphine M. A. Spinler, Jennifer K. Hemarajata, Peera Gao, Chunxu Jones, Sara E. Grimm, Ashley Balderas, Miriam A. Burstein, Matthew D. Morra, Christina Roeth, Daniel Kalkum, Markus and Versalovic, James 2016. FolC2-mediated folate metabolism contributes to suppression of inflammation by probioticLactobacillus reuteri. MicrobiologyOpen,

    Vaghef-Mehrabany, Elnaz Homayouni-Rad, Aziz Alipour, Beitullah Sharif, Sakineh-Khatoun Vaghef-Mehrabany, Leila and Alipour-Ajiry, Serour 2016. Effects of Probiotic Supplementation on Oxidative Stress Indices in Women with Rheumatoid Arthritis: A Randomized Double-Blind Clinical Trial. Journal of the American College of Nutrition, Vol. 35, Issue. 4, p. 291.

    Yang, Menglu Jiang, Ran Liu, Mi Chen, Shujuan He, Li Ao, Xiaoling Zou, Likou Liu, Shuliang and Zhou, Kang 2016. Study of the Probiotic Properties of Lactic Acid Bacteria Isolated from Chinese Traditional Fermented Pickles. Journal of Food Processing and Preservation,

    Guandalini, S. Cernat, E. and Moscoso, D. 2015. Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children. Beneficial Microbes, Vol. 6, Issue. 2, p. 209.

    Owaga, Eddy Hsieh, Rong-Hong Mugendi, Beatrice Masuku, Sakhile Shih, Chun-Kuang and Chang, Jung-Su 2015. Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases. International Journal of Molecular Sciences, Vol. 16, Issue. 9, p. 20841.

    Rodríguez-Nogales, Alba Algieri, Francesca Vezza, Teresa Garrido-Mesa, Natividad Olivares, Mónica Comalada, Mònica Riccardi, Carlo Utrilla, Ma Pilar Rodríguez-Cabezas, Ma Elena and Galvez, Julio 2015. The viability of Lactobacillus fermentum CECT5716 is not essential to exert intestinal anti-inflammatory properties. Food Funct., Vol. 6, Issue. 4, p. 1176.

    Guandalini, Stefano 2014. The Potential for use of Probiotics in Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease. Current Pediatrics Reports, Vol. 2, Issue. 3, p. 235.

    Haag, Lea-Maxie and Siegmund, Britta 2014. Exploring & exploiting our ‘other self’ – Does the microbiota hold the key to the future therapy in Crohn's?. Best Practice & Research Clinical Gastroenterology, Vol. 28, Issue. 3, p. 399.

    Jang, Se-Eun Han, Myung Joo Kim, Se-Young and Kim, Dong-Hyun 2014. Lactobacillus plantarum CLP-0611 ameliorates colitis in mice by polarizing M1 to M2-like macrophages. International Immunopharmacology, Vol. 21, Issue. 1, p. 186.

    Shen, Jun Zuo, Zhi-Xiang and Mao, Ai-Ping 2014. Effect of Probiotics on Inducing Remission and Maintaining Therapy in Ulcerative Colitis, Crohnʼs Disease, and Pouchitis. Inflammatory Bowel Diseases, Vol. 20, Issue. 1, p. 21.

    Woo, Jae-Yeon Gu, Wan Kim, Kyung-Ah Jang, Se-Eun Han, Myung Joo and Kim, Dong-Hyun 2014. Lactobacillus pentosus var. plantarum C29 ameliorates memory impairment and inflammaging in a d-galactose-induced accelerated aging mouse model. Anaerobe, Vol. 27, p. 22.

    Goyal, Nisha Rishi, Praveen and Shukla, Geeta 2013. Lactobacillus rhamnosus GG antagonizes Giardia intestinalis induced oxidative stress and intestinal disaccharidases: an experimental study. World Journal of Microbiology and Biotechnology, Vol. 29, Issue. 6, p. 1049.

    Iida, N. Dzutsev, A. Stewart, C. A. Smith, L. Bouladoux, N. Weingarten, R. A. Molina, D. A. Salcedo, R. Back, T. Cramer, S. Dai, R.-M. Kiu, H. Cardone, M. Naik, S. Patri, A. K. Wang, E. Marincola, F. M. Frank, K. M. Belkaid, Y. Trinchieri, G. and Goldszmid, R. S. 2013. Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment. Science, Vol. 342, Issue. 6161, p. 967.

    Jang, S.-E. Hyam, S.R. Han, M.J. Kim, S.-Y. Lee, B.-G. and Kim, D.-H. 2013. Lactobacillus brevisG-101 ameliorates colitis in mice by inhibiting NF-κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages. Journal of Applied Microbiology, Vol. 115, Issue. 3, p. 888.

    Soldavini, Jessica and Kaunitz, Jonathan D. 2013. Pathobiology and Potential Therapeutic Value of Intestinal Short-Chain Fatty Acids in Gut Inflammation and Obesity. Digestive Diseases and Sciences, Vol. 58, Issue. 10, p. 2756.

    Wang, Yuhua Liu, Yanlong Kirpich, Irina Ma, Zhenhua Wang, Cuiling Zhang, Min Suttles, Jill McClain, Craig and Feng, Wenke 2013. Lactobacillus rhamnosus GG reduces hepatic TNFα production and inflammation in chronic alcohol-induced liver injury. The Journal of Nutritional Biochemistry, Vol. 24, Issue. 9, p. 1609.

    Asemi, Zatollah Jazayeri, Shima Najafi, Mohammad Samimi, Mansoreh Mofid, Vahid Shidfar, Farzad Shakeri, Hossein and Esmaillzadeh, Ahmad 2012. Effect of Daily Consumption of Probiotic Yogurt on Oxidative Stress in Pregnant Women: A Randomized Controlled Clinical Trial. Annals of Nutrition and Metabolism, Vol. 60, Issue. 1, p. 62.

    Atkins, Haydn L. Geier, Mark S. Prisciandaro, Luca D. Pattanaik, Ashok K. Forder, Rebecca E. A. Turner, Mark S. and Howarth, Gordon S. 2012. Effects of a Lactobacillus reuteri BR11 Mutant Deficient in the Cystine-Transport System in a Rat Model of Inflammatory Bowel Disease. Digestive Diseases and Sciences, Vol. 57, Issue. 3, p. 713.

    Foligné, Benoît Peys, Eric Vandenkerckhove, Jan Van hemel, Johan Dewulf, Joëlle Breton, Jérôme and Pot, Bruno 2012. Spores from two distinct colony types of the strain Bacillus subtilis PB6 substantiate anti-inflammatory probiotic effects in mice. Clinical Nutrition, Vol. 31, Issue. 6, p. 987.


A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis

  • Laura Peran (a1), Saleta Sierra (a2), Mònica Comalada (a1), Federico Lara-Villoslada (a2), Elvira Bailón (a1), Ana Nieto (a3), Ángel Concha (a4), Mónica Olivares (a2), Antonio Zarzuelo (a1), Jordi Xaus (a2) and Julio Gálvez (a1)
  • DOI:
  • Published online: 01 January 2007

The intestinal anti-inflammatory effects of two probiotics isolated from breast milk, Lactobacillus reuteri and L. fermentum, were evaluated and compared in the trinitrobenzenesulfonic acid (TNBS) model of rat colitis. Colitis was induced in rats by intracolonic administration of 10 mg TNBS dissolved in 50 % ethanol (0·25 ml). Either L. reuteri or L. fermentum was daily administered orally (5 × 108 colony-forming units suspended in 0·5 ml skimmed milk) to each group of rats (n 10) for 3 weeks, starting 2 weeks before colitis induction. Colonic damage was evaluated histologically and biochemically, and the colonic luminal contents were used for bacterial studies and for SCFA production. Both probiotics showed intestinal anti-inflammatory effects in this model of experimental colitis, as evidenced histologically and by a significant reduction of colonic myeloperoxidase activity (P < 0·05). L. fermentum significantly counteracted the colonic glutathione depletion induced by the inflammatory process. In addition, both probiotics lowered colonic TNFα levels (P < 0·01) and inducible NO synthase expression when compared with non-treated rats; however, the decrease in colonic cyclo-oxygenase-2 expression was only achieved with L. fermentum administration. Finally, the two probiotics induced the growth of Lactobacilli species in comparison with control colitic rats, but the production of SCFA in colonic contents was only increased when L. fermentum was given. In conclusion, L. fermentum can exert beneficial immunomodulatory properties in inflammatory bowel disease, being more effective than L. reuteri, a probiotic with reputed efficacy in promoting beneficial effects on human health.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis
      Available formats
Corresponding author
*Corresponding author: Dr Julio Galvez, fax +34 958248964, email
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

S Boris , R Jimenez-Diaz , JL Caso & C Barbes (2001) Partial characterization of a bacteriocin produced by Lactobacillus delbrueckii subsp. lactis UO004, an intestinal isolate with probiotic potential. J Appl Microbiol 91, 328333

N Borruel , M Carol , F Casellas , M Antolin , F de Lara , E Espin , J Naval , F Guarner & JR Malagelada (2002) Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria. Gut 51, 659664

D Camuesco , M Comalada , ME Rodriguez-Cabezas , A Nieto , MD Lorente , A Concha , A Zarzuelo & J Galvez (2004) The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression. Br J Pharmacol 143, 908918

D Camuesco , L Peran , M Comalada , A Nieto , LC Di Stasi , ME Rodriguez-Cabezas , A Concha , A Zarzuelo & J Galvez (2005) Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis. Inflamm Bowel Dis 11, 265271

CC Chen , S Louie , HN Shi & WA Walker (2005) Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis. Pediatr Res 58, 11851191

HR Christensen , H Frokiaer & JJ Pestka (2002) Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 168, 171178

J Galvez , M Garrido , ME Rodriguez-Cabezas , I Ramis , F Sanchez de Medina , M Merlos & A Zarzuelo (2003) The intestinal anti-inflammatory activity of UR-12746S on reactivated experimental colitis is mediated through downregulation of cytokine production. Inflamm Bowel Dis 9, 363371

P Gionchetti , KM Lammers , F Rizzello & M Campieri (2005) Probiotics and barrier function in colitis. Gut 54, 898900

MB Grisham (1994) Oxidants and free radicals in inflammatory bowel disease. Lancet 344, 859861

MB Grisham , C Olkmer , P Tso & T Yamada (1991) Metabolism of trinitrobenzene sulfonic acid by rat colon produces reactive oxygen species. Gastroenterology 101, 540547

M Heyman , N Darmon , C Dupont , B Dugas , A Hirribaren , MA Blaton & JF Desjeux (1994) Mononuclear cells from infants allergic to cow's milk secrete tumor necrosis factor alpha, altering intestinal function. Gastroenterology 106, 15141523

R Holma , P Salmenpera , J Lohi , H Vapaatalo & R Korpela (2001) Effects of Lactobacillus rhamnosus GG and Lactobacillus reuteri R2LC on acetic acid-induced colitis in rats. Scand J Gastroenterol 36, 630635

AR Jurjus , NN Khoury & JM Reimund (2004) Animal models of inflammatory bowel disease. J Pharmacol Toxicol Methods 50, 8192

C Kunz , S Rudloff , W Baier , N Klein & S Strobel (2000) Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr 20, 699722

D Ma , P Forsythe & J Bienenstock (2004) Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun 72, 53085314

K Madsen , A Cornish , P Soper , C McKaigney , H Jijon , C Yachimec , J Doyle , L Jewell & C De Simone (2001) Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121, 580591

K Madsen , J Doyle , L Jewell , M Tavernini & R Fedorak (1999) Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116, 11071114

Y Mao , S Nobaek , B Kasravi , D Adawi , U Stenram , G Molin & B Jeppsson (1996) The effects of Lactobacillus strains and oat fiber on methotrexate-induced enterocolitis in rats. Gastroenterology 111, 334344

R Martin , S Langa , C Reviriego , E Jiminez , ML Marin , J Xaus , L Fernandez & JM Rodriguez (2003) Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr 143, 754758

R Martin , M Olivares , ML Marin , L Fernandez , J Xaus & JM Rodriguez (2005) Probiotic potential of 3 Lactobacilli strains isolated from breast milk. J Hum Lact 21, 817

PL Moller , A Paerregaard , M Gad , NN Kristensen & MH Claesson (2005) Colitic scid mice fed Lactobacillus spp. show an ameliorated gut histopathology and an altered cytokine profile by local T cells. Inflamm Bowel Dis 11, 814819

GP Morris , PL Beck , W Herridge , W Depew , MR Szewczuk & JL Wallace (1989) Hapten induced model of chronic inflammation and ulceration in rat colon. Gastroenterology 96, 795803

PB Mortensen & MR Clausen (1996) Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scan J Gastroenterol 31, 132S148S

S Pathmakanthan , CK Li , J Cowie & CJ Hawkey (2004) Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamed human colon. J Gastroenterol Hepatol 19, 166173

L Peran , D Camuesco , M Comalada , A Nieto , A Concha , JL Adrio , M Olivares , J Xaus , A Zarzuelo & J Galvez (2006) Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis. Int J Colorectal Dis 21, 737746

BJ Rembacken , AM Snelling , PM Hawkey , DM Chalmers & AT Axon (1999) Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354, 635639

P Rutgeerts , G Van Assche & S Vermeire (2004) Optimizing anti-TNF treatment in inflammatory bowel disease. Gastroenterology 126, 15931610

T Sakata , T Kojima , M Fujieda , M Takahashi & T Michibata (2003) Influences of probiotic bacteria on organic acid production by pig caecal bacteria in vitro. Proc Nutr Soc 62, 7380

RB Sartor (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126, 16201633

M Schultz , HJ Linde , N Lehn , K Zimmermann , J Grossmann , W Falk & J Scholmerich (2003) Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers. J Dairy Res 70, 165173

N Valeur , P Engel , N Carbajal , E Connolly & K Ladefoged (2004) Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol 70, 11761181

A Venturi , P Gionchetti , F Rizzello , R Johansson , E Zucconi , P Brigidi , D Matteuzzi & M Campieri (1999) Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther 13, 11031108

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *